AVENUE THERAPEUTICS, INC. Payments to Acquire in Process Research and Development
AVENUE THERAPEUTICS, INC. (ATXI) reported Payments to Acquire in Process Research and Development of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2018-03-01
- AVENUE THERAPEUTICS, INC. payments to acquire in process research and development for fiscal 2017 was $0.00.
- AVENUE THERAPEUTICS, INC. payments to acquire in process research and development for fiscal 2016 was $0.00.
| Period end | Payments to Acquire in Process Research and Development 11 month | Payments to Acquire in Process Research and Development 12 month |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-01 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-01 | |
| 2015-12-31 | $3.00M 10-K · filed 2018-03-01 |